These compounds inhibited HH pathway activity at nanomolar levels, and they demonstrated efficacy in the ex vivo skin punch mouse BCC model from Ptch1+/− mice described above [40]. The gene discussed is PTCH1; the disease is skin basal cell carcinoma.